DHG Pharmaceutical Stock

Equities

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
111,300 VND -2.71% Intraday chart for DHG Pharmaceutical -4.05% +7.02%
Sales 2024 * 5,263B 205M Sales 2025 * 5,523B 215M Capitalization 14,552B 568M
Net income 2024 * 1,036B 40.42M Net income 2025 * 1,082B 42.21M EV / Sales 2024 * 2.41 x
Net cash position 2024 * 1,859B 72.5M Net cash position 2025 * 1,768B 68.96M EV / Sales 2025 * 2.31 x
P/E ratio 2024 *
14.5 x
P/E ratio 2025 *
13.9 x
Employees 2,789
Yield 2024 *
6.74%
Yield 2025 *
6.74%
Free-Float 48.62%
More Fundamentals * Assessed data
Dynamic Chart
DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
DHG Pharmaceutical Joint Stock Company Announces Change in Personnel CI
DHG Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2022, Payable on May 12, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
DHG Pharmaceutical Joint Stock Company Approves Executive Changes CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
1 day-2.71%
1 week-4.05%
Current month-4.38%
1 month-5.68%
3 months+5.40%
6 months-3.22%
Current year+7.02%
More quotes
1 week
109 000.00
Extreme 109000
115 400.00
1 month
109 000.00
Extreme 109000
119 500.00
Current year
103 100.00
Extreme 103100
120 500.00
1 year
95 000.00
Extreme 95000
140 000.00
3 years
78 000.00
Extreme 78000
142 500.00
5 years
72 400.00
Extreme 72400
142 500.00
10 years
40 000.00
Extreme 40000
142 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO - -
Chief Operating Officer 49 00-02-29
Members of the board TitleAgeSince
Director/Board Member 68 16-08-14
Chief Operating Officer 49 00-02-29
Corporate Officer/Principal 64 89-08-31
More insiders
Date Price Change Volume
24-04-19 111,300 -2.71% 33,600
24-04-17 114,400 -0.17% 3,600
24-04-16 114,600 +0.09% 14,900
24-04-15 114,500 -1.29% 12,600
24-04-12 116,000 +1.31% 7,900

End-of-day quote Ho Chi Minh S.E., April 18, 2024

More quotes
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
111,300 VND
Average target price
116,593 VND
Spread / Average Target
+4.76%
Consensus

Annual profits - Rate of surprise